Prescribers and Patients face greater access and affordability challenges today than ever before. Due to the growing use of formulary restrictions and high-deductible plans, research shows that over 30% of new-to-brand patients will abandon their first fill based on cost. Unfortunately, manufacturer co-pay affordability programs are both complicated and expensive to run. Small gaps and misalignments across a program's strategy, design, execution, and measurement can increase cost and reduce impact. This net sales risk often then creates concern with Senior Leaders. Prescriptive Path puts time back into your team’s day by helping to manage these types of program challenges efficiently.